Trial Profile
A Four-Week Double Blind Multicenter Study Comparing The Efficacy And Safety Of Ziprasidone To Aripiprazole In Subjects With Schizophrenia Or Schizoaffective Disorder Needing Inpatient Care
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Feb 2021
Price :
$35
*
At a glance
- Drugs Aripiprazole (Primary) ; Ziprasidone
- Indications Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- Sponsors Pfizer; Viatris
- 14 Mar 2017 New trial record